EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Methodological Considerations in Assessing Metformin-Associated Vitamin B12 Deficiency

Evangeline A Halog iD, Ray L Mangaoang, Jomar L Aban

Clinical Medicine Insights: Endocrinology and Diabetes · 2026-07 · 19

DOI: 10.1177/11795514261473677 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Medicine Insights: Endocrinology and Diabetes, online erschienen am 25.07.2026. Verfasst von Evangeline A Halog und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rosario Integrated School, Don Mariano Marcos Memorial State University, Agoo, Philippines. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We read the article by Ballal et al (2025) with interest, as it examines the relationship between long-term metformin use and vitamin B12 deficiency in adults with type 2 diabetes. The authors report that patients with deficiency had used metformin for more than 10 years on average, with approximately 17% exhibiting low or borderline serum B12 levels. This study contributes valuable data on vitamin B12 status in an Indian tertiary-care population; however, several methodological limitations affect the interpretation and clinical relevance of the findings. 1 The main limitation of the study is its cross-sectional design, which prevents determination of temporal or causal relationships between metformin use and vitamin B12 deficiency or neuropathy. Without baseline vitamin B12 levels or longitudinal follow-up, it is unclear whether deficiency developed after metformin exposure. Neuropathy in diabetes is multifactorial, involving glycemic control, vascular changes, comorbidities, and nutritional status; therefore, the observed association may reflect overall disease burden rather than a direct effect of metformin. Randomized controlled trials have shown more robust temporal evidence linking metformin use with declining vitamin B12 levels. 2,3 Interpretation is further limited by inadequate control of confounding factors. The study population demonstrated poor glycemic control based on reported HbA1c levels, which is itself a major risk factor for neuropathy and other microvascular complications, yet this was not fully adjusted for in the analysis. In addition, the close relationship between duration of diabetes and duration of metformin use may have introduced confounding. Inclusion of variables such as glycemic control, renal function, dietary intake, and supplement use would have strengthened the analysis. 1

Autor:innen und Institutionen

  • Rosario Integrated School, Don Mariano Marcos Memorial State University, Agoo, Philippines.
  • Don Eufemio F. Eriguel Memorial National High School, Don Mariano Marcos Memorial State University, Agoo, Philippines.
  • Don Mariano Marcos Memorial State University, Bacnotan, Philippines.

ORCID-Profile: Evangeline A Halog

Zitieren

APA

Halog, E. A., Mangaoang, R. L., & Aban, J. L. (2026). Methodological Considerations in Assessing Metformin-Associated Vitamin B12 Deficiency. Clinical Medicine Insights: Endocrinology and Diabetes, 19. https://doi.org/10.1177/11795514261473677

Vancouver

Halog EA, Mangaoang RL, Aban JL. Methodological Considerations in Assessing Metformin-Associated Vitamin B12 Deficiency. Clinical Medicine Insights: Endocrinology and Diabetes. 2026;19. doi:10.1177/11795514261473677

BibTeX
@article{Halog2026,
  author = {Halog, Evangeline A and Mangaoang, Ray L and Aban, Jomar L},
  title = {Methodological Considerations in Assessing Metformin-Associated Vitamin B12 Deficiency},
  journal = {Clinical Medicine Insights: Endocrinology and Diabetes},
  year = {2026},
  volume = {19},
  doi = {10.1177/11795514261473677}
}
Kostenlos starten →